Pegylated interferon alpha-2a plus low-dose ribavirin for the retreatment of dialysis chronic hepatitis C patients who relapsed from prior interferon monotherapy.
Liu
C-H
CH
Liang
C-C
CC
Liu
C-J
CJ
Tsai
H-B
HB
Hung
P-H
PH
Hsu
S-J
SJ
Chen
S-I
SI
Lin
J-W
JW
Lai
M-Y
MY
Chen
J-H
JH
Chen
P-J
PJ
Chen
D-S
DS
Kao
J-H
JH
D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D003956:Dialysis; D004359:Drug Therapy, Combination; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D011994:Recombinant Proteins; D012008:Recurrence; D012254:Ribavirin / Q000627:therapeutic use*
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C100416:peginterferon alfa-2a